PharmaNutra S.p.A. (BIT:PHN), an Italian company specialising in mineral-based nutritional supplements and medical devices for muscles and joints, announced on Wednesday that it has signed an agreement with a strategy consulting company to define the development plan for its US subsidiary.

PharmaNutra USA Corp, based in Florida, distributes and markets PharmaNutra's products in the United States.

Following a recent market analysis, the US consulting firm will work over two months to draft a growth plan in partnership with PharmaNutra. The aim is to enhance business development in the US market, where PharmaNutra has received numerous patents and scientific recognitions from the medical community in recent years.

Roberto Lacorte, PharmaNutra S.p.A. CEO, said: "The design of this plan marks a significant advancement for PharmaNutra USA's business, a project we strongly support. We are pleased to partner with a leading consulting firm that has confirmed the growth drivers identified by PharmaNutra S.p.A. and the substantial potential of the American market for our product range."